The Scientist

» Monsanto

Most Recent

On Tuesday, shareholders at the agribusiness giant approved the $66 billion deal with the European pharmaceutical firm.

0 Comments

image: Science History: The First Transgenic <em>Arabidopsis</em>

Science History: The First Transgenic Arabidopsis

By | October 1, 2016

Tweaks to a transformation protocol in 1986 cemented the little plant's mighty role in plant genetics research.

0 Comments

image: Monsanto Buys Rights to CRISPR

Monsanto Buys Rights to CRISPR

By | September 27, 2016

The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

0 Comments

image: Bayer Looks to Buy Monsanto

Bayer Looks to Buy Monsanto

By | September 14, 2016

The US agribusiness behemoth agreed to a $57 billion buyout offer from the European pharmaceutical giant.

0 Comments

image: E.U. Delays Vote on Roundup

E.U. Delays Vote on Roundup

By | May 24, 2016

Newly published research on the key ingredient in the Monsanto-made weed killer is holding up lawmakers’ decisions on whether to continue to allow its sale in Europe.

4 Comments

image: One Case Closes, Another Opens

One Case Closes, Another Opens

By | September 29, 2014

Unsure of the origins of a rogue crop found on an Oregon farm, the US Department of Agriculture is following up on a second issue related to genetically engineered wheat.

1 Comment

image: Supreme Court Sides with Monsanto

Supreme Court Sides with Monsanto

By | May 15, 2013

The justices unanimously upheld Monsanto’s patent rights on Roundup Ready seeds.

1 Comment

image: Anti-GM Crop Study Gets Audited

Anti-GM Crop Study Gets Audited

By | September 25, 2012

European agencies will evaluate a recent study that links genetically modified corn to early death.

3 Comments

image: A Win for GM Crops

A Win for GM Crops

By | September 10, 2012

The EU Court of Justice struck down Italy’s attempt to block genetically modified maize.

1 Comment

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS